» Articles » PMID: 23699255

Toxin Plasmids of Clostridium Perfringens

Overview
Specialty Microbiology
Date 2013 May 24
PMID 23699255
Citations 113
Authors
Affiliations
Soon will be listed here.
Abstract

In both humans and animals, Clostridium perfringens is an important cause of histotoxic infections and diseases originating in the intestines, such as enteritis and enterotoxemia. The virulence of this Gram-positive, anaerobic bacterium is heavily dependent upon its prolific toxin-producing ability. Many of the ∼16 toxins produced by C. perfringens are encoded by large plasmids that range in size from ∼45 kb to ∼140 kb. These plasmid-encoded toxins are often closely associated with mobile elements. A C. perfringens strain can carry up to three different toxin plasmids, with a single plasmid carrying up to three distinct toxin genes. Molecular Koch's postulate analyses have established the importance of several plasmid-encoded toxins when C. perfringens disease strains cause enteritis or enterotoxemias. Many toxin plasmids are closely related, suggesting a common evolutionary origin. In particular, most toxin plasmids and some antibiotic resistance plasmids of C. perfringens share an ∼35-kb region containing a Tn916-related conjugation locus named tcp (transfer of clostridial plasmids). This tcp locus can mediate highly efficient conjugative transfer of these toxin or resistance plasmids. For example, conjugative transfer of a toxin plasmid from an infecting strain to C. perfringens normal intestinal flora strains may help to amplify and prolong an infection. Therefore, the presence of toxin genes on conjugative plasmids, particularly in association with insertion sequences that may mobilize these toxin genes, likely provides C. perfringens with considerable virulence plasticity and adaptability when it causes diseases originating in the gastrointestinal tract.

Citing Articles

Oral and parenteral vaccination of broiler chickens with Recombinant NetB antigen from Clostridium perfringens confers significant protection against necrotic enteritis.

Shamshirgaran M, Golchin M BMC Vet Res. 2025; 21(1):167.

PMID: 40087742 DOI: 10.1186/s12917-025-04624-z.


Bifidobacterium animalis subsp. lactis A6 ameliorates bone and muscle loss via modulating gut microbiota composition and enhancing butyrate production.

Chen M, Li Y, Zhai Z, Wang H, Lin Y, Chang F Bone Res. 2025; 13(1):28.

PMID: 40000617 PMC: 11862215. DOI: 10.1038/s41413-024-00381-1.


Benzoic Acid, , and Essential Oil Complexes Improve Ovarian and Intestinal Health via Modulating Gut Microbiota in Laying Hens Challenged with and Coccidia.

Zhang H, Liang F, Gong H, Mao X, Ding X, Bai S Animals (Basel). 2025; 15(3).

PMID: 39943069 PMC: 11816253. DOI: 10.3390/ani15030299.


Oral Yeast-Cell Microcapsule-Mediated DNA Vaccines Against Induce Effective Intestinal Immunity and Modulate Gut Microbiota.

Du L, Jia S, Zhang W, Cai C, Liu Y, Wang C Vaccines (Basel). 2025; 12(12.

PMID: 39772022 PMC: 11680129. DOI: 10.3390/vaccines12121360.


Identification of a new variant with a chromosomally encoded enterotoxin gene in a suspected persistent food poisoning outbreak in Eritrea.

Lahti P, Jaakkola K, Horman A, Heikinheimo A, Sovijarvi A, Korkeala H Front Microbiol. 2024; 15:1459840.

PMID: 39529666 PMC: 11552304. DOI: 10.3389/fmicb.2024.1459840.


References
1.
Guttenberg G, Hornei S, Jank T, Schwan C, Lu W, Einsle O . Molecular characteristics of Clostridium perfringens TpeL toxin and consequences of mono-O-GlcNAcylation of Ras in living cells. J Biol Chem. 2012; 287(30):24929-40. PMC: 3408161. DOI: 10.1074/jbc.M112.347773. View

2.
Hardy S, Ritchie C, Allen M, Ashley R, Granum P . Clostridium perfringens type A enterotoxin forms mepacrine-sensitive pores in pure phospholipid bilayers in the absence of putative receptor proteins. Biochim Biophys Acta. 2001; 1515(1):38-43. DOI: 10.1016/s0005-2736(01)00391-1. View

3.
Garnier T, Cole S . Complete nucleotide sequence and genetic organization of the bacteriocinogenic plasmid, pIP404, from Clostridium perfringens. Plasmid. 1988; 19(2):134-50. DOI: 10.1016/0147-619x(88)90052-2. View

4.
Goni F, Alonso A . Sphingomyelinases: enzymology and membrane activity. FEBS Lett. 2002; 531(1):38-46. DOI: 10.1016/s0014-5793(02)03482-8. View

5.
Llosa M, Gomis-Ruth F, Coll M, de la Cruz Fd F . Bacterial conjugation: a two-step mechanism for DNA transport. Mol Microbiol. 2002; 45(1):1-8. DOI: 10.1046/j.1365-2958.2002.03014.x. View